The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy

Mesenchymal stromal cells (MSCs) are characterized by paracrine and immunomodulatory functions capable of changing the microenvironment of damaged brain tissue toward a more regenerative and less inflammatory milieu. The authors conducted a phase 2, single-center, assessor-blinded randomized control...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cytotherapy (Oxford, England) England), 2021-09, Vol.23 (9), p.833-840
Hauptverfasser:	Law, Zhe Kang, Tan, Hui Jan, Chin, Sze Piaw, Wong, Chee Yin, Wan Yahya, Wan Nur Nafisah, Muda, Ahmad Sobri, Zakaria, Rozman, Ariff, Mohd Izhar, Ismail, Nor Azimah, Cheong, Soon Keng, S Abdul Wahid, S. Fadilah, Mohamed Ibrahim, Norlinah
Format:	Artikel
Sprache:	eng
Schlagworte:	clinical trial ischemic stroke mesenchymal stromal cells middle cerebral artery infarction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!